Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants
Clinical trial NCT07666750 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07666750
- Sponsor
- International Vaccine Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-08-01
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.